The Paul-Ehrlich-Institut in Germany says it will support the Food and Drugs Authority (FDA) in becoming a regional centre of excellence for the regulation of blood and blood products in West Africa.
Speaking to Citi News on Tuesday, June 2, at the “Road to Compliance” stakeholders meeting, the Head of the BloodTrain Project at the institute, Dr Jens Reinhardt, said the partnership could position Ghana’s FDA to share expertise and best practices with regulators across the region.
“One of the goals of the Bloodtrain project that I am heading is to support the FDA Ghana to be a regional centre of regulatory excellence and regulation of blood-to-blood products.
The knowledge we develop at FDA Ghana will be disseminated to neighbouring countries. We also support the harmonisation of blood-to-blood products in Africa,” he said.
He noted that although the FDA has made significant progress in strengthening regulatory activities in recent years, some challenges still need to be addressed, adding that the institute is committed to supporting those efforts.
Dr Reinhardt also stressed the need to strike a balance between regulatory requirements and the practical realities on the ground to ensure effective implementation.
